BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15581411)

  • 1. Cannabinoid/opioid crosstalk in the central nervous system.
    Corchero J; Manzanares J; Fuentes JA
    Crit Rev Neurobiol; 2004; 16(1-2):159-72. PubMed ID: 15581411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms underlying the interaction between cannabinoid and opioid system.
    Parolaro D; Rubino T; Viganò D; Massi P; Guidali C; Realini N
    Curr Drug Targets; 2010 Apr; 11(4):393-405. PubMed ID: 20017730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular basis of cannabinoid and opioid interactions.
    Viganò D; Rubino T; Parolaro D
    Pharmacol Biochem Behav; 2005 Jun; 81(2):360-8. PubMed ID: 15927245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the field of cannabinoid--opioid cross-talk.
    Robledo P; Berrendero F; Ozaita A; Maldonado R
    Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and reward: interactions with the opioid system.
    Fattore L; Cossu G; Spano MS; Deiana S; Fadda P; Scherma M; Fratta W
    Crit Rev Neurobiol; 2004; 16(1-2):147-58. PubMed ID: 15581410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses.
    Maldonado R; Valverde O
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):401-10. PubMed ID: 14636956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
    Viganò D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
    Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid-opioid interactions during neuropathic pain and analgesia.
    Bushlin I; Rozenfeld R; Devi LA
    Curr Opin Pharmacol; 2010 Feb; 10(1):80-6. PubMed ID: 19857996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of endogenous cannabinoids in cerebral reward mechanisms].
    Wenger T; Fürst S
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):26-9. PubMed ID: 15125311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interactions between the opioid and cannabinoid systems].
    Beaulieu P
    Ann Fr Anesth Reanim; 2000 Mar; 19(3):217-8. PubMed ID: 10782249
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabinoid receptors and pain.
    Pertwee RG
    Prog Neurobiol; 2001 Apr; 63(5):569-611. PubMed ID: 11164622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and biochemical interactions between opioids and cannabinoids.
    Manzanares J; Corchero J; Romero J; Fernández-Ruiz JJ; Ramos JA; Fuentes JA
    Trends Pharmacol Sci; 1999 Jul; 20(7):287-94. PubMed ID: 10390647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids as potential new analgesics.
    Fuentes JA; Ruiz-Gayo M; Manzanares J; Vela G; Reche I; Corchero J
    Life Sci; 1999; 65(6-7):675-85. PubMed ID: 10462068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids, opioids and eating behavior: the molecular face of hedonism?
    Cota D; Tschöp MH; Horvath TL; Levine AS
    Brain Res Rev; 2006 Jun; 51(1):85-107. PubMed ID: 16364446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and pain.
    Lever IJ; Rice AS
    Handb Exp Pharmacol; 2007; (177):265-306. PubMed ID: 17087127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids.
    Grotenhermen F
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective.
    Karst M; Wippermann S
    Expert Opin Investig Drugs; 2009 Feb; 18(2):125-33. PubMed ID: 19236260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional role of the endocannabinoid system in emotional homeostasis].
    Marco EM; Viveros MP
    Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.
    Manzanares J; Ortiz S; Oliva JM; Pérez-Rial S; Palomo T
    Alcohol Alcohol; 2005; 40(1):25-34. PubMed ID: 15550451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.